Related Experiment Video

Updated: Jul 19, 2026

Utilizing Murine Inducible Telomerase Alleles in the Studies of Tissue Degeneration/Regeneration and Cancer
08:34

Utilizing Murine Inducible Telomerase Alleles in the Studies of Tissue Degeneration/Regeneration and Cancer

Published on: April 13, 2015

Telomerase inhibition in cancer therapeutics: molecular-based approaches

A P Cunningham1, W K Love, R W Zhang

  • 1Department of Biology, University of Alabama at Birmingham, AL 35294, USA.

Current Medicinal Chemistry
|November 1, 2006
PubMed

Insights

Targeting telomerase, an enzyme common in cancer cells but not normal ones, offers a new strategy for cancer treatment. This review explores pharmacogenomic methods to inhibit telomerase, potentially reducing side effects of traditional therapies.

Area of Science:

  • Oncology
  • Pharmacogenomics
  • Molecular Biology

Background:

  • Standard cancer therapies like chemotherapy and radiation cause significant off-target side effects.
  • Telomerase is highly expressed in most human cancers, making it a promising therapeutic target.
  • Developing targeted cancer therapies aims to destroy cancer cells while sparing normal tissues.

Purpose of the Study:

  • To review recent pharmacogenomic approaches for telomerase inhibition in cancer therapy.
  • To analyze strategies for exploiting differential telomerase expression for targeted cancer treatment.
  • To examine the synergistic potential of telomerase inhibitors with conventional cancer agents.

Main Methods:

  • Review of pharmacogenomic strategies for telomerase inhibition.
  • Discussion of antisense oligonucleotides, RNA interference, and ribozymes.
  • Analysis of mutant telomerase expression and targeted oncolysis approaches.

Main Results:

  • Several pharmacogenomic approaches show potential for precise telomerase inhibition.
  • Targeted oncolysis strategies leverage differential telomerase expression.
  • Synergistic effects observed between telomerase inhibitors and traditional cancer treatments.

Conclusions:

  • Pharmacogenomic inhibition of telomerase represents a promising avenue for developing targeted cancer therapies.
  • Targeted strategies can potentially minimize the adverse effects associated with conventional chemotherapy and radiation.
  • Further research into telomerase inhibition, particularly its synergistic potential, is warranted for advancing cancer treatment.

More Related Videos

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis11:44

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis

Published on: March 30, 2019

In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice07:02

In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice

Published on: August 23, 2019

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Replicative Cell Senescence02:15

Replicative Cell Senescence

Replicative cell senescence is a property of cells that allows them to divide a finite number of times throughout the organism's lifespan while preventing excessive proliferation. Replicative senescence is associated with the gradual loss of the telomere — short, repetitive DNA sequences found at the end of the chromosomes. Telomeres are bound by a group of proteins to form a protective cap on the ends of chromosomes. Embryonic stem cells express telomerase — an enzyme that adds the telomeric...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Telomeres and Telomerase02:41

Telomeres and Telomerase

In eukaryotic DNA replication, a single-stranded DNA fragment remains at the end of a chromosome after the removal of the final primer. This section of DNA cannot be replicated in the same manner as the rest of the strand because there is no 3’ end to which the newly synthesized DNA can attach. This non-replicated fragment results in gradual loss of the chromosomal DNA during each cell duplication. Additionally, it can induce a DNA damage response by enzymes that recognize single-stranded DNA.